arrow
S

Shunsaku Nakagawa

kyoto university
H指数:23
被引数:1,764

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A rare variant in DPYD c.812delT causes severe adverse events of S-1 in a patient with tongue cancer

DPYD基因c.812delT罕见变异导致舌癌患者使用S-1药物产生严重不良反应

2026-08-030
OAAI
Complexation of teicoplanin and sulfobutylether-β-cyclodextrin: experimental and theoretical insights into the potential relevance of their molecular interaction to teicoplanin pharmacokinetics

替考拉宁与磺丁基醚-β-环糊精的络合作用:对其分子相互作用与替考拉宁药代动力学潜在相关性的实验与理论见解

2026-07-010
OAAI
Valganciclovir therapeutic drug monitoring-guided dosing for cytomegalovirus prophylaxis in lung transplant patients

肺移植患者巨细胞病毒预防中基于万古西洛韦治疗药物监测的剂量指导

2026-06-010
PRE
Sleep Architecture Alterations Following High-Dose Steroid Pulse Therapy: A Pilot Study Using a Portable Electroencephalogram-Based Device

高剂量糖皮质激素冲击疗法后的睡眠结构改变:一项使用便携式脑电图设备的初步研究

2025-12-010
OAAI
NUDT15 Genetic Polymorphism as a Risk Factor for Early Neutropenia During Valganciclovir Prophylaxis in Lung Transplant Patients

NUDT15基因多态性作为肺移植患者使用缬更昔洛韦预防期间发生早期中性粒细胞减少症的危险因素

2025-09-180
OAAI
CYP2C19-Guided Voriconazole Therapy: A Precision Medicine Approach to Mitigate Adverse Effects in Japanese Patients

CYP2C19-Guided Voriconazole Therapy:一种用于减轻日本患者不良反应的精准医学方法

2025-08-180
OAAI
Comparison of cisplatin-based versus standard preoperative chemotherapy in patients with operable triple-negative breast cancer: propensity score matching and inverse probability of treatment weighting analysis
2023-12-211
OAAI
N-terminus of Etanercept is Proteolytically Processed by Dipeptidyl Peptidase-4

依那西普的N-末端被二肽基Peptidase-4蛋白水解处理

2022-08-190
PRE
First-in-Human Evaluation of Positron Emission Tomography/Computed Tomography With [18F]FB(ePEG12)12-Exendin-4: A Phase 1 Clinical Study Targeting GLP-1 Receptor Expression Cells in Pancreas
2021-08-1918
OAAI